Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_assertion type Assertion NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_head.
- NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_provenance.
- NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_assertion evidence source_evidence_literature NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_provenance.
- NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_assertion SIO_000772 17607666 NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_provenance.
- NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_assertion wasDerivedFrom befree-2016 NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_provenance.
- NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_assertion wasGeneratedBy ECO_0000203 NP618250.RAHf22nTxf8jait2FxQNJ_Wk6Kc1x8JyGdLk-3QUN4NBI130_provenance.